Benchmark Financial Wealth Advisors LLC lifted its stake in The Procter & Gamble Company (NYSE:PG – Free Report) by 11.0% during the third quarter, HoldingsChannel.com reports. The firm owned 1,832 shares of the company’s stock after purchasing an additional 182 shares during the quarter. Benchmark Financial Wealth Advisors LLC’s holdings in Procter & Gamble were worth $317,000 as of its most recent SEC filing.
Other hedge funds also recently added to or reduced their stakes in the company. Itau Unibanco Holding S.A. purchased a new position in Procter & Gamble in the 2nd quarter worth approximately $28,000. Fairway Wealth LLC purchased a new position in Procter & Gamble in the 2nd quarter worth approximately $29,000. Ruedi Wealth Management Inc. raised its holdings in Procter & Gamble by 64.7% in the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after acquiring an additional 77 shares during the last quarter. POM Investment Strategies LLC purchased a new position in Procter & Gamble in the 2nd quarter worth approximately $34,000. Finally, Quest Partners LLC purchased a new position in Procter & Gamble in the 2nd quarter worth approximately $36,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
Procter & Gamble Trading Up 0.4 %
Shares of PG stock opened at $165.79 on Wednesday. The Procter & Gamble Company has a 52-week low of $142.50 and a 52-week high of $177.94. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The firm has a market capitalization of $390.44 billion, a PE ratio of 28.58, a PEG ratio of 3.57 and a beta of 0.42. The stock has a fifty day simple moving average of $171.45 and a two-hundred day simple moving average of $168.18.
Procter & Gamble Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a $1.0065 dividend. The ex-dividend date is Friday, October 18th. This represents a $4.03 annualized dividend and a yield of 2.43%. Procter & Gamble’s dividend payout ratio is currently 69.48%.
Insider Buying and Selling
In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the firm’s stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of $168.99, for a total value of $2,163,072.00. Following the completion of the sale, the insider now owns 11,566 shares of the company’s stock, valued at $1,954,538.34. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other news, CEO Jon R. Moeller sold 37,240 shares of Procter & Gamble stock in a transaction that occurred on Wednesday, August 28th. The shares were sold at an average price of $168.89, for a total transaction of $6,289,463.60. Following the completion of the sale, the chief executive officer now owns 263,537 shares of the company’s stock, valued at approximately $44,508,763.93. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Balaji Purushothaman sold 12,800 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 24th. The shares were sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the sale, the insider now directly owns 11,566 shares of the company’s stock, valued at $1,954,538.34. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 385,771 shares of company stock worth $65,610,975. Corporate insiders own 0.18% of the company’s stock.
Wall Street Analysts Forecast Growth
PG has been the subject of a number of research reports. Stifel Nicolaus boosted their target price on shares of Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a research note on Monday, July 22nd. StockNews.com lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Morgan Stanley boosted their target price on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research note on Monday, October 21st. DA Davidson boosted their target price on shares of Procter & Gamble from $159.00 to $160.00 and gave the company a “neutral” rating in a research note on Monday, October 21st. Finally, Evercore ISI boosted their target price on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research note on Monday, October 21st. Nine research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, Procter & Gamble currently has an average rating of “Moderate Buy” and an average target price of $177.00.
View Our Latest Stock Report on Procter & Gamble
About Procter & Gamble
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
See Also
- Five stocks we like better than Procter & Gamble
- What is MarketRank™? How to Use it
- 2 Alternative Internet Stocks Staging a Breakout in 2024
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Discover the 3 Best-Performing Biotech IPO Stocks of 2024
- What is the Shanghai Stock Exchange Composite Index?
- Hims & Hers: Why This Healthcare Stock’s Growth Makes It a Buy
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.